Christou Evangelos, Iliodromiti Zoe, Pouliakis Abraham, Sokou Rozeta, Zantiotou Matina, Petropoulou Chrisa, Boutsikou Theodora, Iacovidou Nicoletta
Neonatal Department, Aretaieio Hospital, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
PICU, Panagiotis and Aglaia Kyriakou Children's Hospital, 115 27 Athens, Greece.
Diagnostics (Basel). 2022 Jun 8;12(6):1416. doi: 10.3390/diagnostics12061416.
The detection of NT-proBNP levels both in umbilical cord blood (UCB) samples and in serum samples collected from healthy term neonates during the neonatal period. A systematic review of relevant literature in accordance with PRISMA guidelines was conducted. For quality appraisal, the potential risk of bias was assessed using the BIOCROSS evaluation tool. The random-effects and fixed-effects models were used to calculate weighted mean differences with a corresponding 95% confidence interval. A total of forty (40) studies met the inclusion criteria for the systematic review. After further examination, eighteen (18) studies (1738 participants) from the UCB sample group and fourteen (14) studies (393 participants) from the serum sample group were selected to perform a meta-analysis. Using the fixed-effects model, the mean intervals of NT-proBNP in UCB and serum samples were 492 pg/mL (95% CI: 480−503 pg/mL) and 1341 pg/mL (95% CI: 1286−1397 pg/mL), respectively. A higher concentration of ΝΤ-proBNP was observed in the serum sample group compared to the UCB samples (p < 0.001). We present the intervals of NT-proBNP in UCB and in the serum of healthy term neonates. The determination of the potential effect of perinatal factors on the biomarker’s reference range was also aimed.
检测新生儿期脐带血(UCB)样本以及健康足月儿血清样本中的NT-proBNP水平。按照PRISMA指南对相关文献进行了系统综述。为进行质量评估,使用BIOCROSS评估工具评估潜在的偏倚风险。采用随机效应模型和固定效应模型计算加权平均差及相应的95%置信区间。共有40项研究符合系统综述的纳入标准。进一步筛选后,选择了脐带血样本组的18项研究(1738名参与者)和血清样本组的14项研究(393名参与者)进行荟萃分析。采用固定效应模型,脐带血样本和血清样本中NT-proBNP的平均区间分别为492 pg/mL(95%CI:480−503 pg/mL)和1341 pg/mL(95%CI:1286−1397 pg/mL)。与脐带血样本组相比,血清样本组中观察到更高浓度的NT-proBNP(p < 0.001)。我们给出了健康足月儿脐带血和血清中NT-proBNP的区间。本研究还旨在确定围产期因素对该生物标志物参考范围的潜在影响。